Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Incontinence, Stress | 12 | 2013 | 32 | 1.290 |
Why?
|
| Norpregnadienes | 2 | 2010 | 3 | 0.660 |
Why?
|
| Contraception, Postcoital | 2 | 2010 | 3 | 0.660 |
Why?
|
| BCG Vaccine | 1 | 2021 | 110 | 0.660 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 119 | 0.660 |
Why?
|
| Mortality | 1 | 2021 | 261 | 0.610 |
Why?
|
| Pelvic Floor | 4 | 2007 | 37 | 0.560 |
Why?
|
| Urinary Incontinence | 7 | 2024 | 73 | 0.520 |
Why?
|
| Vaccination | 3 | 2021 | 1043 | 0.510 |
Why?
|
| Exercise Therapy | 2 | 2007 | 175 | 0.460 |
Why?
|
| Uterine Prolapse | 6 | 2008 | 23 | 0.400 |
Why?
|
| Gynecologic Surgical Procedures | 5 | 2014 | 68 | 0.340 |
Why?
|
| Pregnancy, Unwanted | 1 | 2010 | 4 | 0.340 |
Why?
|
| Puerperal Disorders | 2 | 2007 | 50 | 0.320 |
Why?
|
| Contraceptives, Postcoital, Hormonal | 1 | 2010 | 1 | 0.320 |
Why?
|
| Postpartum Period | 3 | 2007 | 236 | 0.300 |
Why?
|
| Fecal Incontinence | 5 | 2024 | 73 | 0.300 |
Why?
|
| Voluntary Health Agencies | 1 | 2007 | 5 | 0.280 |
Why?
|
| Condylomata Acuminata | 1 | 2007 | 15 | 0.270 |
Why?
|
| Leprosy | 3 | 2021 | 16 | 0.260 |
Why?
|
| Malawi | 6 | 2021 | 339 | 0.250 |
Why?
|
| Tuberculosis | 3 | 2021 | 555 | 0.250 |
Why?
|
| Forests | 2 | 2023 | 14 | 0.250 |
Why?
|
| Pelvic Floor Disorders | 2 | 2024 | 12 | 0.240 |
Why?
|
| Ecosystem | 2 | 2023 | 97 | 0.230 |
Why?
|
| Counseling | 1 | 2007 | 237 | 0.230 |
Why?
|
| Vaginosis, Bacterial | 2 | 2019 | 18 | 0.220 |
Why?
|
| Health Care Costs | 1 | 2007 | 400 | 0.210 |
Why?
|
| Pelvic Organ Prolapse | 2 | 2014 | 31 | 0.200 |
Why?
|
| Trees | 2 | 2023 | 20 | 0.200 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2003 | 29 | 0.200 |
Why?
|
| Treatment Outcome | 14 | 2021 | 13011 | 0.200 |
Why?
|
| Biodiversity | 2 | 2023 | 77 | 0.190 |
Why?
|
| Immunogenicity, Vaccine | 2 | 2021 | 123 | 0.190 |
Why?
|
| Anal Canal | 3 | 2007 | 86 | 0.180 |
Why?
|
| Urogenital Surgical Procedures | 3 | 2008 | 11 | 0.180 |
Why?
|
| Follow-Up Studies | 6 | 2021 | 5298 | 0.180 |
Why?
|
| Antiviral Agents | 1 | 2007 | 813 | 0.180 |
Why?
|
| Mycobacterium leprae | 1 | 2021 | 5 | 0.180 |
Why?
|
| Vagina | 4 | 2013 | 215 | 0.180 |
Why?
|
| Female | 33 | 2024 | 71316 | 0.170 |
Why?
|
| Smallpox | 1 | 2020 | 12 | 0.160 |
Why?
|
| Smallpox Vaccine | 1 | 2020 | 39 | 0.160 |
Why?
|
| Streptococcal Vaccines | 1 | 2019 | 18 | 0.150 |
Why?
|
| Pregnancy | 9 | 2010 | 7577 | 0.150 |
Why?
|
| Bacterial Capsules | 1 | 2019 | 42 | 0.150 |
Why?
|
| Tuberculin Test | 1 | 1999 | 120 | 0.150 |
Why?
|
| Adult | 18 | 2021 | 31734 | 0.150 |
Why?
|
| Double-Blind Method | 2 | 2021 | 1638 | 0.140 |
Why?
|
| Humans | 38 | 2024 | 131967 | 0.140 |
Why?
|
| Streptococcal Infections | 1 | 2019 | 248 | 0.120 |
Why?
|
| Urinary Bladder | 4 | 2008 | 249 | 0.120 |
Why?
|
| Middle Aged | 15 | 2021 | 28911 | 0.110 |
Why?
|
| Oral Health | 1 | 2014 | 28 | 0.110 |
Why?
|
| Athletic Performance | 1 | 2014 | 13 | 0.110 |
Why?
|
| Delivery, Obstetric | 2 | 2007 | 259 | 0.110 |
Why?
|
| Aged | 12 | 2021 | 21279 | 0.100 |
Why?
|
| Haemophilus influenzae type b | 1 | 2013 | 5 | 0.100 |
Why?
|
| Haemophilus Vaccines | 1 | 2013 | 32 | 0.100 |
Why?
|
| Patient Education as Topic | 2 | 2007 | 466 | 0.100 |
Why?
|
| Immunization Schedule | 1 | 2013 | 111 | 0.100 |
Why?
|
| Haemophilus Infections | 1 | 2013 | 97 | 0.100 |
Why?
|
| Drug Therapy, Combination | 2 | 2007 | 1173 | 0.090 |
Why?
|
| Combined Modality Therapy | 2 | 2007 | 1261 | 0.090 |
Why?
|
| Quality of Life | 5 | 2008 | 2116 | 0.090 |
Why?
|
| Suburethral Slings | 2 | 2008 | 9 | 0.090 |
Why?
|
| Health Surveys | 1 | 2012 | 263 | 0.090 |
Why?
|
| Contraceptives, Postcoital | 1 | 2010 | 1 | 0.090 |
Why?
|
| Ovulation Inhibition | 1 | 2010 | 1 | 0.090 |
Why?
|
| Young Adult | 3 | 2021 | 10108 | 0.090 |
Why?
|
| Surveys and Questionnaires | 5 | 2007 | 4058 | 0.090 |
Why?
|
| Contraceptives, Oral, Synthetic | 1 | 2010 | 5 | 0.080 |
Why?
|
| Administration, Oral | 2 | 2010 | 710 | 0.080 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2010 | 26 | 0.080 |
Why?
|
| Levonorgestrel | 1 | 2010 | 20 | 0.080 |
Why?
|
| Unsafe Sex | 1 | 2010 | 23 | 0.080 |
Why?
|
| Odds Ratio | 3 | 2013 | 1236 | 0.080 |
Why?
|
| Parity | 2 | 2007 | 84 | 0.080 |
Why?
|
| Adolescent | 7 | 2021 | 21008 | 0.080 |
Why?
|
| Menstrual Cycle | 1 | 2010 | 35 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2012 | 397 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2009 | 3843 | 0.070 |
Why?
|
| Surgical Mesh | 2 | 2013 | 65 | 0.070 |
Why?
|
| Urethra | 3 | 2013 | 85 | 0.070 |
Why?
|
| Child, Preschool | 4 | 2021 | 15066 | 0.070 |
Why?
|
| Trichloroacetic Acid | 1 | 2007 | 5 | 0.070 |
Why?
|
| Urologic Surgical Procedures | 1 | 2008 | 62 | 0.070 |
Why?
|
| Cryotherapy | 1 | 2007 | 15 | 0.070 |
Why?
|
| Aminoquinolines | 1 | 2007 | 36 | 0.070 |
Why?
|
| Tinidazole | 1 | 2007 | 1 | 0.070 |
Why?
|
| Antitrichomonal Agents | 1 | 2007 | 10 | 0.070 |
Why?
|
| Child | 6 | 2021 | 26332 | 0.060 |
Why?
|
| Physical Examination | 2 | 2004 | 170 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2009 | 232 | 0.060 |
Why?
|
| Prevalence | 3 | 2012 | 2697 | 0.060 |
Why?
|
| Lacerations | 1 | 2006 | 32 | 0.060 |
Why?
|
| Postoperative Complications | 4 | 2013 | 3135 | 0.060 |
Why?
|
| Endosonography | 1 | 2006 | 79 | 0.060 |
Why?
|
| Male | 9 | 2021 | 65357 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2009 | 5122 | 0.060 |
Why?
|
| Cesarean Section | 3 | 2007 | 436 | 0.060 |
Why?
|
| Domestic Violence | 1 | 2005 | 12 | 0.060 |
Why?
|
| Preoperative Care | 1 | 2008 | 357 | 0.060 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2024 | 9 | 0.060 |
Why?
|
| Spouses | 1 | 2005 | 70 | 0.050 |
Why?
|
| Sex Offenses | 1 | 2005 | 52 | 0.050 |
Why?
|
| Abortion, Induced | 1 | 2005 | 85 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2013 | 1255 | 0.050 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2009 | 500 | 0.050 |
Why?
|
| Truth Disclosure | 1 | 2005 | 109 | 0.050 |
Why?
|
| Medical History Taking | 1 | 2004 | 109 | 0.050 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2004 | 133 | 0.050 |
Why?
|
| Brazil | 1 | 2023 | 140 | 0.050 |
Why?
|
| Texas | 3 | 2007 | 3629 | 0.050 |
Why?
|
| Research Design | 2 | 2024 | 723 | 0.050 |
Why?
|
| Debridement | 1 | 2003 | 90 | 0.050 |
Why?
|
| Influenza, Human | 1 | 2009 | 704 | 0.050 |
Why?
|
| Methods | 2 | 1996 | 115 | 0.050 |
Why?
|
| Aged, 80 and over | 5 | 2012 | 6922 | 0.050 |
Why?
|
| Case-Control Studies | 4 | 2013 | 3453 | 0.040 |
Why?
|
| Hysterectomy, Vaginal | 1 | 2001 | 20 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2009 | 1519 | 0.040 |
Why?
|
| Time Factors | 1 | 2010 | 6285 | 0.040 |
Why?
|
| Singapore | 1 | 2020 | 16 | 0.040 |
Why?
|
| Monkeypox virus | 1 | 2020 | 5 | 0.040 |
Why?
|
| London | 1 | 2020 | 15 | 0.040 |
Why?
|
| Ghana | 1 | 2020 | 21 | 0.040 |
Why?
|
| United States | 2 | 2024 | 11827 | 0.040 |
Why?
|
| Israel | 1 | 2020 | 48 | 0.040 |
Why?
|
| Nigeria | 1 | 2020 | 69 | 0.040 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1999 | 32 | 0.040 |
Why?
|
| Risk | 2 | 2013 | 739 | 0.040 |
Why?
|
| Peru | 1 | 2019 | 56 | 0.040 |
Why?
|
| Vaccines, Conjugate | 1 | 2019 | 83 | 0.040 |
Why?
|
| Tropical Climate | 1 | 2019 | 50 | 0.040 |
Why?
|
| Streptococcus agalactiae | 1 | 2019 | 102 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2024 | 558 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2003 | 3095 | 0.030 |
Why?
|
| Health Status Indicators | 2 | 2008 | 124 | 0.030 |
Why?
|
| Urinary Bladder Diseases | 2 | 2006 | 34 | 0.030 |
Why?
|
| Rural Population | 1 | 1999 | 260 | 0.030 |
Why?
|
| Episiotomy | 2 | 2007 | 17 | 0.030 |
Why?
|
| Models, Statistical | 1 | 1999 | 493 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 427 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 812 | 0.030 |
Why?
|
| Urodynamics | 2 | 2006 | 38 | 0.030 |
Why?
|
| Oral Hygiene | 1 | 2014 | 9 | 0.030 |
Why?
|
| Colposcopy | 1 | 2014 | 17 | 0.030 |
Why?
|
| Defecation | 1 | 2014 | 35 | 0.030 |
Why?
|
| Sacrococcygeal Region | 1 | 2014 | 37 | 0.030 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2014 | 85 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 2148 | 0.030 |
Why?
|
| Patient Satisfaction | 2 | 2008 | 460 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2008 | 17703 | 0.030 |
Why?
|
| Athletes | 1 | 2014 | 72 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2003 | 3708 | 0.030 |
Why?
|
| Longitudinal Ligaments | 1 | 2013 | 3 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2013 | 353 | 0.020 |
Why?
|
| Health Behavior | 1 | 2014 | 390 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 2578 | 0.020 |
Why?
|
| Reoperation | 1 | 2014 | 844 | 0.020 |
Why?
|
| Ultrasonography | 1 | 1996 | 976 | 0.020 |
Why?
|
| Health Promotion | 1 | 2014 | 408 | 0.020 |
Why?
|
| Incidence | 2 | 2012 | 3352 | 0.020 |
Why?
|
| Anti-Retroviral Agents | 1 | 2012 | 153 | 0.020 |
Why?
|
| Infant | 3 | 1999 | 13332 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2012 | 244 | 0.020 |
Why?
|
| Health Status | 1 | 2012 | 388 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 895 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2012 | 277 | 0.020 |
Why?
|
| United Kingdom | 1 | 2009 | 255 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 244 | 0.020 |
Why?
|
| Urinary Catheterization | 1 | 1988 | 80 | 0.020 |
Why?
|
| Risk Factors | 3 | 2007 | 10998 | 0.020 |
Why?
|
| Urinary Incontinence, Urge | 1 | 2007 | 4 | 0.020 |
Why?
|
| Translations | 1 | 2007 | 18 | 0.020 |
Why?
|
| Urination | 1 | 2007 | 27 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1988 | 144 | 0.020 |
Why?
|
| Flatulence | 1 | 2006 | 6 | 0.020 |
Why?
|
| Perineum | 1 | 2006 | 49 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 741 | 0.010 |
Why?
|
| Language | 1 | 2007 | 220 | 0.010 |
Why?
|
| Pain | 1 | 1988 | 439 | 0.010 |
Why?
|
| Skin | 1 | 1988 | 553 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2007 | 469 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1626 | 0.010 |
Why?
|
| Psychometrics | 1 | 2007 | 678 | 0.010 |
Why?
|
| Random Allocation | 1 | 2003 | 423 | 0.010 |
Why?
|
| Suture Techniques | 1 | 2003 | 180 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2003 | 442 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2007 | 1695 | 0.010 |
Why?
|
| Medical Records | 1 | 2001 | 181 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 2992 | 0.010 |
Why?
|
| Hospital Costs | 1 | 2001 | 180 | 0.010 |
Why?
|
| HIV Infections | 1 | 2012 | 2042 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2008 | 6522 | 0.010 |
Why?
|
| Length of Stay | 1 | 2001 | 1400 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 1987 | 95 | 0.000 |
Why?
|